Dr Reddys Laboratories RDY
NYSE RDY
$14.90 +0.38 (+2.62%)
At close: Nov 6, 2026 · 4:00 PM EST

Dr Reddys Laboratories (RDY) Revenue (2009 - 2026)

Updated

Dr Reddys Laboratories (RDY) posted Revenue of $907.15 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 10.1% from $1.01 billion a year earlier but up 6.4% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Revenue (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Revenue at Dr Reddys Laboratories was $3.56 billion, down 10.5% year-over-year; for FY2026 (ended Mar 31, 2026), it was $3.58 billion, down 6.1% from FY2025.

  • Annual Revenue shows a five-year compound annual growth rate of 6.7% (FY2021 to FY2026).
  • In prior fiscal years, Dr Reddys Laboratories' Revenue was $3.81 billion in FY2025 (+13.8%), $3.35 billion in FY2024 (+12.0%), $2.99 billion in FY2023 (+5.9%) and $2.83 billion in FY2022 (+8.9%).
  • Quarterly Revenue has run from a low of $717 million in fiscal Q3 2022 to a high of $1.01 billion in fiscal Q2 2026 over five years.
  • On a year-over-year basis, Revenue has declined in each of the last four quarters, with growth averaging 0.2% over the last eight quarters.
  • The strongest year-over-year quarter for Revenue in the past five years was fiscal Q2 2023, with growth of 17.5%; the weakest was fiscal Q4 2026, with a decline of 16.3%.
  • According to Business Quant data, Revenue for the three prior fiscal quarters was $852.47 million (Q1 2027), $822.21 million (Q4 2026) and $979.97 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 25.40 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 17.40 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 15.07 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 8.30 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 16.58 Bn
10 Dr Reddys Laboratories 12.40 Bn 11.74 Bn 472.93 Mn 907.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 907.15 Mn
Jun 30, 2026 852.47 Mn
Mar 31, 2026 822.21 Mn
Dec 31, 2025 979.97 Mn
Sep 30, 2025 1.01 Bn
Jun 30, 2025 998.48 Mn
Mar 31, 2025 982.28 Mn
Dec 31, 2024 989.97 Mn
Sep 30, 2024 957.09 Mn
Jun 30, 2024 919.78 Mn
Mar 31, 2024 852.90 Mn
Dec 31, 2023 866.49 Mn
Sep 30, 2023 832.30 Mn
Jun 30, 2023 828.00 Mn
Mar 31, 2023 811.00 Mn
Dec 31, 2022 767.00 Mn
Sep 30, 2022 824.00 Mn
Jun 30, 2022 762.00 Mn
Mar 31, 2022 723.04 Mn
Dec 31, 2021 717.00 Mn
API Access

Dr Reddys Laboratories Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=RDY&period=max&api_key=YOUR_API_KEY